It’s impossible to stop all the factors that cause colibacillosis. But with Poulvac® E. coli, the only commercially available modified-live Escherichia coli (E. coli) vaccine, it is possible to help protect against both the disease and productivity loss.
Poulvac® E. coli is recommended for mass administration to healthy chickens and turkeys 1 day of age or older. It’s the only modified-live E. coli vaccine available that’s demonstrated to be safe for birds in helping protect U.S. poultry operations against this costly threat.1
The product has demonstrated to help improve bird health in all major segments of commercial poultry production:
1 Data on file, Study Reports No. TIA 23370 and TIA 21371, Zoetis LLC.
2 Data on file, Study Report No. B510-09-RFT.R, Zoetis LLC.
3 Data on file, Study Report No. PPH-0006, Zoetis LLC.
4 Data on file, Study Report No. FD-08-2, Zoetis LLC.
E. coli risk factors:
Area viral challenges, including Infectious Bronchitis (IB)